Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pretreatment Expectations and Treatment Outcome in Early Lyme Borreliosis
NCT03462329Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jun 2018
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of doxycycline in Lyme disease (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Occurrence of objective clinical manifestations of Lyme borreliosis and post-Lyme symptoms at 12 months. Started Jun 2018; status: recruiting.
02
Drugs
doxycycline
03
Conditions
Lyme disease
Beyond the preview
Go deeper on NCT03462329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03462329.